CVS Health Corp (CVS) : Wills Financial Group scooped up 7,030 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 30,323 shares of CVS Health Corp which is valued at $2,304,548.CVS Health Corp makes up approximately 2.05% of Wills Financial Group’s portfolio.
Other Hedge Funds, Including , Paulson added CVS to its portfolio by purchasing 122,200 company shares during the most recent quarter which is valued at $9,287,200. CVS Health Corp makes up approx 0.11% of Paulson’s portfolio.Main Street Research reduced its stake in CVS by selling 1,068 shares or 21.87% in the most recent quarter. The Hedge Fund company now holds 3,816 shares of CVS which is valued at $294,900. CVS Health Corp makes up approx 0.06% of Main Street Research’s portfolio.Pathstone Family Office reduced its stake in CVS by selling 48 shares or 23.08% in the most recent quarter. The Hedge Fund company now holds 160 shares of CVS which is valued at $12,365. CVS Health Corp makes up approx 0.01% of Pathstone Family Office’s portfolio.Sumitomo Mitsui Asset Management Company Ltd reduced its stake in CVS by selling 1,287 shares or 1.52% in the most recent quarter. The Hedge Fund company now holds 83,169 shares of CVS which is valued at $6,940,453. CVS Health Corp makes up approx 0.16% of Sumitomo Mitsui Asset Management Company Ltd’s portfolio.Hermes Investment Management Ltd boosted its stake in CVS in the latest quarter, The investment management firm added 88,103 additional shares and now holds a total of 872,004 shares of CVS Health Corp which is valued at $72,690,253. CVS Health Corp makes up approx 1.26% of Hermes Investment Management Ltd’s portfolio.
CVS Health Corp closed down -0.23 points or -0.31% at $74.04 with 74,98,481 shares getting traded on Monday. Post opening the session at $74.03, the shares hit an intraday low of $73.67 and an intraday high of $74.56 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, CVS Health Corp reported $1.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Nov 8, 2016. Analyst had a consensus of $1.57. The company had revenue of $44615.00 million for the quarter, compared to analysts expectations of $45294.50 million. The company’s revenue was up 15.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.29 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Shares were Reiterated by Mizuho on Nov 9, 2016 to “Buy” and Lowered the Price Target to $ 90 from a previous price target of $111 .
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.